In:
Blood Advances, American Society of Hematology, Vol. 2, No. 16 ( 2018-08-28), p. 2079-2089
Abstract:
A drop in platelet count 〉 25% relative to baseline at 6 months from diagnosis predicts inferior outcome in lower-risk MDS. Platelet drop combined with RBC-TD at 6 months provides an inexpensive and validated classifier of outcome in lower-risk MDS.
Type of Medium:
Online Resource
ISSN:
2473-9529
,
2473-9537
DOI:
10.1182/bloodadvances.2018020495
Language:
English
Publisher:
American Society of Hematology
Publication Date:
2018
detail.hit.zdb_id:
2876449-3
Permalink